Stay updated on Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.1 to v3.7.2 while the page remains a 403 Forbidden error screen.
    Difference
    0.2%
    Check dated 2026-10-18T01:47:31.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:27:54.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The study-record page displays a 403 Forbidden message and a Home link instead of the clinical-trial details.
    Difference
    0.5%
    Check dated 2026-10-04T02:01:16.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details. The error page blocks access to the trial content and related navigation.
    Difference
    18%
    Check dated 2026-09-20T01:24:44.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, reflecting a minor update to the site's framework rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-29T20:30:02.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.5, indicating a new version of the ClinicalTrials.gov record. This reflects a minor administrative update to the page rather than substantive changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T11:06:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.